MARKET

MENS

MENS

Jyong Biotech Ltd.
NASDAQ
2.080
+0.180
+9.47%
Opening 14:45 03/31 EDT
OPEN
1.900
PREV CLOSE
1.900
HIGH
2.090
LOW
1.880
VOLUME
132.76K
TURNOVER
--
52 WEEK HIGH
67.00
52 WEEK LOW
1.430
MARKET CAP
158.14M
P/E (TTM)
-119.5402
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MENS last week (0323-0327)?
Weekly Report · 1d ago
Jyong Biotech updates MCS-2 BPH/LUTS program; Phase III trials span 27 U.S. centers in 19 states
Reuters · 4d ago
Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2
Barchart · 4d ago
Weekly Report: what happened at MENS last week (0316-0320)?
Weekly Report · 03/23 09:05
Weekly Report: what happened at MENS last week (0309-0313)?
Weekly Report · 03/16 09:05
Weekly Report: what happened at MENS last week (0302-0306)?
Weekly Report · 03/09 09:05
Weekly Report: what happened at MENS last week (0223-0227)?
Weekly Report · 03/02 09:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 02/25 21:07
More
About MENS
Jyong Biotech Ltd is a Taiwan-based science-driven biotechnology company. The Company is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The Company has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.

Webull offers Jyong Biotech Ltd. stock information, including NASDAQ: MENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MENS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MENS stock methods without spending real money on the virtual paper trading platform.